Acute Respiratory Distress Syndrome (ARDS) Diagnosis and Management

Clinical Presentation and Diagnosis

The American Thoracic Society recommends that ARDS be diagnosed based on the presence of severe hypoxemia (PO2 5 kPa/38 mmHg, SpO2 78%) with preserved ventilation (normal pH, PCO2, HCO3), and tachypnea, which are hallmarks of Type 1 respiratory failure from ventilation-perfusion mismatch and intrapulmonary shunting 1, 2, 3
The European Society of Intensive Care Medicine suggests that ARDS typically develops 1-5 days after the initial insult, and the patient's presentation on day 5 post-respiratory infection is consistent with this timeline 1
The Society of Critical Care Medicine recommends that patients with post-infectious ARDS be identified based on the presence of progressive dyspnea, severe hypoxemia, and tachypnea, which are characteristic features of ARDS 1, 2, 3

The American College of Chest Physicians explains that severe hypoxemia in ARDS occurs through two primary mechanisms: ventilation-perfusion (V/Q) mismatch and intrapulmonary shunting, which result in areas of perfused but non-ventilated lung and completely collapsed or fluid-filled alveoli without gas exchange 1
The European Respiratory Society notes that the normal PCO2 despite severe hypoxemia in ARDS occurs because CO2 is 20 times more diffusible than oxygen, allowing even diseased alveoli to eliminate CO2 effectively while failing to oxygenate blood 4

The American College of Emergency Physicians recommends that immediate oxygen therapy be initiated in patients with ARDS, with a target SpO2 of 94-98%, and that mechanical ventilation be prepared if oxygen therapy fails 5, 6
The Society of Critical Care Medicine suggests that arterial blood gas analysis be obtained to confirm diagnosis and guide ventilatory support in patients with ARDS 5, 4

The American Thoracic Society advises against withholding oxygen due to concerns about CO2 retention when PO2 is critically low (5 kPa), as the immediate risk of hypoxic brain injury outweighs theoretical hypercapnia concerns 5, 6
The European Society of Intensive Care Medicine recommends against delaying treatment while obtaining chest X-ray, as radiographic changes in ARDS often lag behind physiological derangements by hours to days 1

The American Thoracic Society recommends that COPD typically presents with Type 2 respiratory failure (hypercapnia with elevated PCO2), which is not consistent with this patient's normal PCO2 7, 8
The European Respiratory Society suggests that daytime hypercapnia is unlikely in COPD patients unless respiratory muscle strength is reduced to 40% of predicted 9
Respiratory depressant drug overdoses cause hypoventilation with elevated PCO2, which is not consistent with this patient's normal PCO2 and normal pH 8
The American College of Chest Physicians states that neuromuscular weakness causes Type 2 respiratory failure with hypercapnia when severe enough to cause hypoxemia, which is not consistent with this patient's normal PCO2 9, 8

The British Thoracic Society recommends immediate oxygen therapy with a target SpO2 of 94-98%, and mechanical ventilation should be prepared if oxygen therapy fails 7
High-flow oxygen should be started immediately in patients with severe hypoxemia, such as this patient with SpO2 78% 7
The Infectious Diseases Society of America suggests that clinical examination alone is not reliable for diagnosing severe hypoxemia, and arterial blood gas analysis should be obtained to confirm diagnosis and guide ventilatory support 10